ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

June 16, 1995

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

2018 State of Cancer Care in America

February 3, 2022

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

National Cancer Survey Data Available Soon: NCI Will Invite Investigators to Prepare Analysis

August 23, 1974